Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • 1
    News

    HM17 session summary: Updates in Antibiotics – Determining duration and when to switch to PO

    August 1, 2017

    Antibiotic stewardship is more than narrowing coverage once susceptibilities are available. It also means conversion of antibiotics to oral therapy when clinically appropriate.

  • 1
    News

    Association between concurrent use of prescription opiates and benzos

    July 31, 2017

    Clinical Question: What is the impact of concurrent benzodiazepine use in chronic versus intermittent opioid use on risk for opioid overdose?

  • 1
    Video

    VIDEO: How to discharge new pediatric diabetes cases in 2 days 

    July 28, 2017

    Can children who present to the hospital with new-onset diabetes be discharged sooner?

  • 1
    News

    C diff infection among U.S. ED patients

    July 27, 2017

    Clinical Question: Should all emergency department (ED) patients with diarrhea, without vomiting, get tested for Clostridium difficile?

  • 1
    News

    PEARL score for COPD exacerbations

    July 26, 2017

    Which prognostic score is best at predicting 90-day readmission and mortality for patients admitted with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?

  • 1
    Opinion

    Student Hospitalist Scholars: Preventing unplanned PICU transfers

    July 25, 2017

    SHM Student Hospitalist Scholar Farah Hussain wants to help design interventions to prevent pediatric clinical deterioration and unplanned transfers to the PICU.

  • 1
    News

    Large-scale implementation of the I-PASS handover system

    July 25, 2017

    Clinical Question: Is a system-wide I-PASS handover system able to be effectively implemented?

  • 1
    News

    CCDSSs to prevent VTE

    July 24, 2017

    Do computerized clinical decision support systems (CCDSSs) decrease the risk of venous thromboembolism (VTE) in surgical patients?

  • 1
    News

    Rivaroxaban or aspirin for extended treatment of VTE

    July 21, 2017

    Is full or lower intensity rivaroxaban better for extended treatment of venous thromboembolism (VTE) as compared to aspirin?

  • 1
    News

    Corticosteroid therapy in Kawasaki disease

    July 20, 2017

    Corticosteroids combined with intravenous immunoglobulin as initial therapy for Kawasaki disease showed a more protective effect against coronary artery abnormalities, compared with conventional IVIG therapy.

Previous1 … 281 282 283 284 285 … 401Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences